U.S. Gas Utilities Stock News

Space Exploration Technologies has fallen sharply this year, yet its valuation checks still suggest the stock is not a clear bargain even after the pullback. With the market treating it as an overvalued growth story and short interest elevated, investors are weighing rich expectations against recent price weakness. Year to date, Space Exploration Technologies is down 32.7%, which means recent buyers have faced a steep drawdown even as interest in AI and space infrastructure remains...

We wouldn't blame Old Republic International Corporation ( NYSE:ORI ) shareholders if they were a little worried about...

CACI International has nearly doubled shareholders' money over the past five years. With the stock around US$497.75 and a mixed value score, the current price does not look like a clear bargain or a clear stretch either. The stock has returned about 97.3% over five years, which sets a high bar for anyone buying CACI International today to expect similar gains. The recent US$500m counter drone contract and SkyValor deployment can support long term revenue visibility. At the same time, the...

DNOW Inc. (DNOW) has set August 6, 2026, for its second quarter earnings release and conference call, giving investors a fresh look at the distributor's performance and capital allocation priorities. See our latest analysis for DNOW. At a share price of $14.12, DNOW has seen a 10.31% 1 month share price return and a 5.69% year to date share price return, while the 1 year total shareholder return declined 4.21% and the 5 year total shareholder return is 79.42%. This suggests shorter term...

What the UAE ANKTIVA approval means for ImmunityBio stock ImmunityBio (IBRX) is back on investor radar after the Emirates Drug Establishment in the UAE granted marketing authorization for ANKTIVA across two cancer indications, expanding the therapy’s global regulatory footprint. The decision covers ANKTIVA in combination with BCG for BCG unresponsive non muscle invasive bladder cancer and with immune checkpoint inhibitors for metastatic non small cell lung cancer. For shareholders, the...

Equinix (EQIX) has been active in the capital markets, completing several fixed income offerings that include senior callable fixed rate notes across 2029, 2033 and 2036 maturities, alongside additional fixed rate note announcements. See our latest analysis for Equinix. Equinix shares have eased in the short term, with the share price down 2.70% over one day and 5.99% over seven days. However, the year to date share price return of 33.39% and 1 year total shareholder return of 35.08% still...

Kyivstar Group stock has delivered a 30.1% return over the past year, yet its current checks point to pricing that looks broadly in line with fundamentals rather than clearly cheap or clearly expensive. The 30.1% one year gain puts recent shareholders comfortably ahead, which raises the question of how much of Kyivstar Group's progress is already reflected in the share price. Growth in digital services and new partnerships around areas such as AI and mobility can support revenue...

Boston Scientific (BSX) is back in focus after its 29 July 2026 earnings release, which included updated 2026 sales guidance and fresh detail on restructuring, product pressures and a recent device recall. See our latest analysis for Boston Scientific. Boston Scientific’s recent earnings beat, updated guidance and the recall news have come against a backdrop of mixed momentum, with the 1 month share price return of 8.52% contrasting with a year to date share price decline of 50.66% and a 1...

SouthState Bank has delivered a 64.0% total return over the past 5 years, yet its current share price of US$105.09 still screens as cheap against an intrinsic value estimate from the Excess Returns model and traditional market multiples. With several valuation checks pointing in the same direction, investors are weighing whether the current discount reflects mispricing or a fair assessment of the bank’s risks. Over the last 5 years SouthState Bank has returned 64.0%, which already represents...

Shareholders in World Kinect Corporation ( NYSE:WKC ) may be thrilled to learn that the analysts have just delivered a...

AbCellera Biologics (NasdaqGS:ABCL) shares are in focus after the company announced a new collaboration with Vertex Pharmaceuticals to discover, develop, manufacture, and commercialize multispecific T cell engagers for autoimmune diseases. See our latest analysis for AbCellera Biologics. The Vertex deal lands at a time when AbCellera Biologics has shown mixed momentum, with a 7.53% 7 day share price return, a 28.89% 90 day share price return, and a 34.67% 1 year total shareholder return,...

Recently, Analog Devices attracted increased investor attention after analysts raised their earnings estimates and Zacks assigned the company a Rank #2 (Buy), signaling stronger profit expectations across its core markets. This shift in forecasts highlights how changing views on Analog Devices’ earnings power in automation, AI, and electrification can reshape its broader investment appeal. Now we’ll examine how these upward earnings estimate revisions may influence Analog Devices’ existing...

Flutter Entertainment stock is down 65.1% over the past year. Yet the broader valuation checks still lean toward the shares looking cheap rather than fully priced. With sentiment starting to shift after recent research pointing to easing concerns around prediction markets, the gap between weak past returns and a supportive valuation read is back in focus for investors. Over the last 12 months, Flutter Entertainment has declined 65.1%, which means the market has already priced in a...

PayPal Holdings (PYPL) has just reported second quarter 2026 results, with higher sales and lower net income compared with a year ago. The update gives investors fresh numbers to assess the stock. See our latest analysis for PayPal Holdings. PayPal Holdings’ recent earnings beat and higher full year guidance sit against a mixed price picture. A 29.82% 1 month share price return contrasts with a 14.01% decline in 1 year total shareholder return, suggesting short term momentum but a weaker...

In late July 2026, Frontier Group Holdings, Inc. reported second-quarter results showing revenue rising to US$1,279 million from US$929 million a year earlier, while net loss widened to US$90 million and loss per share increased to US$0.39. Over the first half of 2026, revenue climbed to US$2,271 million from US$1,841 million, but net loss more than tripled to US$362 million, highlighting pressure on profitability despite higher sales. We’ll now examine how Frontier’s revenue growth...

In late July 2026, Teladoc Health reported second‑quarter results showing sales declining to US$606.93 million and a wider net loss of US$38.91 million, alongside lower basic loss per share from continuing operations of US$0.21. Management also issued guidance calling for continued losses in the third quarter and full year 2026, highlighting ongoing pressure from the BetterHelp mental health unit as more users move toward insurance-covered care. We’ll now examine how Teladoc’s weaker...

Some City Holding Company ( NASDAQ:CHCO ) shareholders may be a little concerned to see that the President, Charles...

Anyone interested in World Acceptance Corporation ( NASDAQ:WRLD ) should probably be aware that the Executive VP, John...

In July 2026, Elanco Animal Health reported new study results showing its Credelio Quattro chewable tablets kill black-legged and lone star ticks faster and more consistently through Day 28 than competing products Simparica Trio and NexGard Plus, while also carrying an FDA-approved claim for Lyme disease prevention in dogs. An important angle for investors is that Credelio Quattro’s rapid tick kill and Lyme prevention claim differentiate it within a crowded pet parasiticide market,...

Lucid Group (LCID) is drawing attention after a 2.01% gain in its latest session and more than 20% share price appreciation over the past month. The move comes ahead of its August 4 earnings report. See our latest analysis for Lucid Group. Lucid Group’s recent gains sit against a weaker backdrop, with the share price down 33.81% year to date and the 1 year total shareholder return declining 69.50%. The latest momentum hints at shifting expectations around growth and risk ahead of earnings. If...

In July 2026, EnerSys updated its plans for a Greenville, South Carolina lithium cell plant, narrowing its focus to U.S.-based production for aerospace, defense, and specialized industrial customers, backed by an approximately US$150 million revised U.S. Department of Energy grant and about US$200 million in state and local incentives toward an estimated US$500 million investment. The shift away from its Verkor technology relationship toward long-standing aerospace and defense partners...

Booz Allen Hamilton Holding (BAH) has come into focus after quarterly results were well received despite a year over year revenue decline, with management pointing to disciplined execution and improved contract performance. See our latest analysis for Booz Allen Hamilton Holding. For context, Booz Allen Hamilton Holding's share price has risen 16.18% over the past month yet remains down 17.87% year to date, while the 1 year total shareholder return is down 34.73%. This suggests recent...

Procter & Gamble (PG) has entered a transitional phase that is drawing fresh attention from investors. Softer fiscal 2027 guidance, leadership changes, and recent margin pressure are all converging to reshape the conversation around the stock. See our latest analysis for Procter & Gamble. At a share price of US$144.49, Procter & Gamble has had a modest 1.9% year to date share price return, while the 1 year total shareholder return is down 1.27%. This suggests that momentum has cooled as...

Nebius Group recently secured a multiyear AI cloud contract worth more than US$1 billion, activated new Nvidia-powered capacity in Finland, and arranged a US$775 million senior secured debt facility to fund its global AI infrastructure expansion. These deals, backed by long-dated commitments from large technology customers and collateralized GPU assets, highlight how Nebius is tying its growth plans directly to contracted AI compute demand rather than relying solely on equity financing. With...